辽宁奥克化学股份有限公司 关于控股股东部分股份质押的公告 证券代码：300082 证券简称：奥克股份 公告编号：2024-006 辽宁奥克化学股份有限公司 关于控股股东部分股份质押的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示：辽宁奥克化学股份有限公司（以下简称"公司"）控股股东 奥克控股集团股份公司（以下简称"奥克集团"）持有公司股份359,698,573股， 占公司总股本的52.89%。本次股份质押2,000,000股后，奥克集团累计质押数量为 47,620,000股，占其持股数量的13.24%，占公司总股本的7.00%。 | 股东名 | 持股数量 | 持股比 | 本次质押 | 本次质押 | 占其所 | 占公 | 已质押股份情况 | 未质押股份情 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 称 | （股） | 例 | 前质押股 | 后质押股 | 持股份 | 司总 | | 况 | 1 公司于2024年3月29日接到控股股东奥克集团通知，获悉奥克集团将其所持 有的公司部 ...

辽宁奥克化学股份有限公司 关于控股股东部分股份质押的公告 证券代码：300082 证券简称：奥克股份 公告编号：2024-005 辽宁奥克化学股份有限公司 关于控股股东部分股份质押的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示：辽宁奥克化学股份有限公司（以下简称"公司"）控股股东 奥克控股集团股份公司（以下简称"奥克集团"）持有公司股份359,698,573股， 占公司总股本的52.89%。本次股份质押3,000,000股后，奥克集团累计质押数量为 45,620,000股，占其持股数量的12.68%，占公司总股本的6.71%。 公司于2024年3月22日接到控股股东奥克集团通知，获悉奥克集团将其所持 有的公司部分股份办理了质押手续，具体事项如下： 本次质押股份不涉及被用作重大资产重组业绩补偿等事项担保或其他保障 用途的情形。 二、股东股份累计质押情况 截至公告披露日，控股股东奥克集团所持股份质押情况如下： | 股东名 | 持股数量 | 持股比 | 本次质押 | 本次质押 | 占其所 | 占公 | 已质押股份情况 | 未质押股份情 | | --- ...

辽宁奥克化学股份有限公司 关于控股股东部分股份解除质押的公告 1、本次解除质押基本情况 | 股东名称 | | 是否为控股 股东或第一 | 本次解除 | 占其所持 | 占公司总 | 质押起始 | 质押解除 | 质权人 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 大股东及一 致行动人 | 质押股数 （股） | 股份比例 | 股本比例 | 日 | 日 | | | 奥克控股集团 股份公司 | | 是 | 14,710,000 | 4.09% | 2.16% | 2023.1.3 | 2024.3.15 | 华夏银行股份 有限公司沈阳 | | | | | | | | | | 长白支行 | | 合 | 计 | - | 14,710,000 | 4.09% | 2.16% | | | | 2、股东股份累计质押情况 证券代码：300082 证券简称：奥克股份 公告编号：2024-004 辽宁奥克化学股份有限公司 关于控股股东部分股份解除质押的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 辽宁 ...

辽宁奥克化学股份有限公司 关于更换签字注册会计师的公告 证券代码：300082 证券简称：奥克股份 公告编号：2024-003 辽宁奥克化学股份有限公司 关于更换签字注册会计师的公告 签字会计师张玉萍，2003年成为注册会计师，2017年开始从事上市公司审计， 2019年开始在中审众环执业，近三年签署上市公司审计报告2家，具有证券服务 业务从业经验，具备相应的专业胜任能力。 2、诚信记录 张玉萍近三年未受到任何刑事处罚，未因执业行为受到证监会及其派出机构、 行业主管部门等的行政处罚或监督管理措施，未因执业行为受到证券交易所、行 业协会等自律组织的监管措施、纪律处分。张玉萍不存在违反《中国注册会计师 职业道德守则》对独立性要求的情形。 3、独立性 1 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 辽宁奥克化学股份有限公司（以下简称"公司"） 于2023年4月17日召开第 六届董事会第四次会议、第六届监事会第三次会议，审议通过了《关于续聘2023 年度会计师事务所的议案》，同意续聘中审众环会计师事务所（特殊普通合伙） （以下简称"中审众环事务所"）为公司2023年度审 ...

证券代码：300082 证券简称：奥克股份 公告编号：2024-002 辽宁奥克化学股份有限公司 关于控股股东部分股份质押的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示：辽宁奥克化学股份有限公司（以下简称"公司"）控股股东 奥克控股集团股份公司（以下简称"奥克集团"）持有公司股份359,698,573股， 占公司总股本的52.89%。本次股份质押9,240,000股后，奥克集团累计质押数量为 57,330,000股，占其持股数量的15.94%，占公司总股本的8.43%。 辽宁奥克化学股份有限公司 关于控股股东部分股份质押的公告 公司于2024年3月1日接到控股股东奥克集团通知，获悉奥克集团将其所持有 的公司部分股份办理了质押手续，具体事项如下： | | 是否为控 | | 占其 | | | 是否 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东名 | 股股东或 | 本次质押股 | 所持 | 占公司 | 是否 | 为补 | 质押起始 ...

辽宁奥克化学股份有限公司 关于海南奥克 20 万吨/年 环氧衍生绿色能源新材料项目投产的公告 证券代码：300082 证券简称：奥克股份 公告编号：2023-052 辽宁奥克化学股份有限公司 关于海南奥克20万吨/年环氧衍生绿色能源新材料项目 投产的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、项目概述 2020年12月13日，辽宁奥克化学股份有限公司（以下简称"公司"或"奥克 股份"）与海南洋浦经济开发区管理委员会（以下简称"洋浦管委会"）签订《洋 浦环氧乙烷下游衍生物项目投资协议》，协议约定公司在海南洋浦拟投资建设环 氧乙烷下游衍生物项目，其中一期项目为"海南洋浦20万吨环氧乙烷配套衍生产 品项目"（实际立项批复项目名称为"20万吨/年环氧衍生绿色能源新材料项目"， 以下简称"海南奥克项目"），公司拟采用自筹等多种方式筹集资金投资4.5亿 元建设环氧乙烷衍生精细化工新材料产品。 海南奥克项目投资是奥克股份"立足环氧衍生绿色低碳精细化学品及新能源 新材料创造价值"的发展战略布局的重要组成部分，是奥克股份面向东盟市场和 沿着海上丝绸之路开发国际市场的战略 ...

辽宁奥克化学股份有限公司 辽宁奥克化学股份有限公司 2023 年第三季度报告 证券代码：300082 证券简称：奥克股份 公告编号：2023-050 辽宁奥克化学股份有限公司 3.第三季度报告是否经过审计 □是 否 1 篇 辽宁奥克化学股份有限公司 辽宁奥克化学股份有限公司 2023 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 2023 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大 遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、完 整。 公司是否需追溯调整或重述以前年度会计数据 日是 ☑否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增減 | | 年同期增减 | | 营业收入(元) ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥2,040,052,741.10, a decrease of 30.10% compared to ¥2,918,733,978.94 in the same period last year[24]. - The net profit attributable to shareholders of the listed company was a loss of ¥150,119,945.46, a decline of 414.24% from a profit of ¥47,772,219.73 in the previous year[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥159,127,058.38, down 549.79% from ¥35,377,898.72 in the same period last year[24]. - The basic earnings per share for the reporting period was -¥0.22, compared to ¥0.07 in the previous year, reflecting a decrease of 414.29%[24]. - The total assets at the end of the reporting period were ¥5,958,451,254.09, a decrease of 7.14% from ¥6,416,452,608.88 at the end of the previous year[24]. - The net assets attributable to shareholders of the listed company were ¥3,101,011,876.14, down 4.47% from ¥3,246,157,096.43 at the end of the previous year[24]. - The net cash flow from operating activities was ¥41,883,606.16, a slight decrease of 3.17% compared to ¥43,252,569.17 in the same period last year[24]. - The weighted average return on net assets was -4.73%, a decline of 6.15% from 1.42% in the previous year[24]. - The company achieved operating revenue of CNY 204,005.27 million in the first half of 2023, a year-on-year decline of 30.10%[47]. - The net profit attributable to shareholders was CNY -15,011.99 million, primarily due to decreased sales revenue from the main product, polycarboxylate superplasticizer, resulting in a significant drop in gross profit[47]. Market and Industry Trends - In the first half of 2023, China's GDP grew by 5.5%, while fixed asset investment increased by 3.8% to 243.113 billion yuan[36]. - The real estate development investment in China decreased by 7.9% to 58.55 billion yuan in the first half of 2023, with new construction area down by 24.91%[36]. - The demand for lithium battery electrolytes has surged due to explosive growth in the lithium battery market, which is one of the four key materials for lithium batteries[34]. - The market demand for polycarboxylic acid superplasticizers is expected to maintain stable growth, with a current market capacity surplus leading to intense price competition[37]. - In the first half of 2023, China's new energy vehicle production and sales reached 3.788 million and 3.745 million units, respectively, representing year-on-year growth of 42.78% and 44.54%[37]. - The cumulative sales of power batteries in China reached 256.5 GWh in the first half of 2023, with a year-on-year growth of 17.5%[37]. - The export of new energy vehicles from China in the first half of 2023 was 534,000 units, a year-on-year increase of 160%[37]. - The domestic pharmaceutical excipients market is expected to grow in line with the rapid growth of the pharmaceutical manufacturing industry, which has seen a compound annual growth rate of over 20% in the past decade[39]. - The demand for non-ionic surfactants is projected to grow steadily, driven by increased consumer hygiene awareness and the rising demand for personal care products[40]. Strategic Initiatives and Innovations - The company has a strategic capacity layout of 1.6 million tons of ethoxylation capacity across Northeast, East China, South China, Central China, and Southwest regions[32]. - The company has an annual production capacity of 300,000 tons of ethylene oxide and possesses world-leading production technology for ethylene carbonate and dimethyl carbonate[32]. - The company is actively adjusting its ethylene import procurement and domestic trade procurement ratios to reduce raw material procurement costs[36]. - The company focuses on high-end technology industrialization in epoxy and green low-carbon fine chemical materials, forming a complete industrial chain from ethylene to epoxy[32]. - The company has developed a proprietary production process for ethylene carbonate and dimethyl carbonate, which is recognized as a world-first and has significant competitive advantages in quality and cost[42]. - The company is focusing on the development of high-end products in the fields of new energy battery materials and green low-carbon series products derived from ethylene oxide and carbon dioxide[43]. - The company has established international platforms in Indonesia and Singapore to implement its international development strategy[33]. - The company has established partnerships with well-known enterprises in the electrolyte industry, enhancing the market competitiveness of its carbonate products[46]. - The company has implemented a centralized procurement model to optimize supply channels and enhance procurement efficiency, significantly reducing production costs[45]. - The company has invested 100 million CNY in R&D for innovative technologies aimed at reducing emissions by 25% over the next three years[110]. Environmental Compliance and Sustainability - The company emphasizes the importance of safety and environmental protection in its operations, particularly in the storage and transportation of hazardous chemicals like ethylene and ethylene oxide[83]. - The company is classified as a key pollutant discharge unit according to environmental protection regulations[96]. - The company has been actively involved in compliance with multiple environmental protection laws and standards, including the Environmental Protection Law and the Water Pollution Prevention Law[96]. - The company has implemented emergency response plans for environmental incidents, valid until May 11, 2026[99]. - The company’s VOCs emissions were recorded at 0.12 tons, which is compliant with the national air pollution discharge standards[99]. - The company has a valid hazardous chemical operation license valid until November 19, 2023, for its Guangdong subsidiary[99]. - The company has established a technical center for environmental impact assessments, with the approval received in 2008[97]. - The company has implemented measures to reduce carbon emissions by utilizing resources efficiently and promoting green development[120]. - The company has not faced any administrative penalties due to environmental issues during the reporting period[119]. - The company has received approval for the environmental impact report of the annual production of 30,000 tons of epoxy ethane-derived fine chemicals, with the approval number 辽市行审发【2017】272号 dated January 2, 2018[97]. Shareholder and Corporate Governance - The company emphasizes the protection of shareholder and creditor rights, ensuring transparency and compliance with legal regulations[121]. - The company has a strong commitment to employee rights, ensuring equal employment opportunities and competitive compensation[122]. - The company maintains good relationships with suppliers and customers, focusing on integrity and high-quality service[123]. - The performance commitment for the acquisition of 67% of the shares in Aoke Pharmaceutical Auxiliary Co., Ltd. includes a net profit of no less than 28 million yuan for 2020, 25.94 million yuan for 2021, 31.03 million yuan for 2022, and 36.10 million yuan for 2023[130]. - If the actual net profit falls below the committed net profit, the controlling shareholders will compensate using shares or cash, with Aoke Group responsible for 51.02% and Dalian Jixing for 48.98%[130]. - The company has not experienced any non-operating fund occupation by controlling shareholders or related parties during the reporting period[133]. - There were no violations regarding external guarantees during the reporting period[134]. - The semi-annual financial report has not been audited[135]. - The company reported a litigation amount of 175.75 million yuan related to performance commitment compensation and equity impairment compensation[137]. - The company has recognized a bad debt provision of 7.5 million yuan for accounts receivable related to ongoing litigation[137]. Future Outlook and Growth Strategies - The company expects a revenue growth of 10% for the second half of 2023, driven by new product launches and market expansion strategies[110]. - New product development includes the launch of a new line of eco-friendly chemical products, projected to contribute 200 million CNY in revenue by the end of 2023[110]. - The company plans to expand its market presence in Southeast Asia, targeting a 20% market share in the region within the next two years[110]. - A strategic acquisition of a local competitor is anticipated to be finalized by Q4 2023, expected to enhance production capacity by 30%[110]. - The company has implemented cost-cutting measures that are expected to save approximately 50 million CNY annually[110]. - Future guidance indicates a focus on sustainability initiatives, with a goal to achieve carbon neutrality by 2025[110].

辽宁奥克化学股份有限公司 独立董事关于第六届董事会第七次会议相关事项的独立意见 公司本次与各关联方之间预计发生的日常关联交易均为满足公司日常生产经营 所需。关联交易的价格均参照市场价格进行协商确定，定价公允合理，不存在违反 公平、公正原则，不存在损害公司及股东利益的情形，符合公司整体利益。同时， 该关联交易事项的审议及表决程序符合相关法律法规及《公司章程》的有关规定， 关联董事在审议相关关联交易事项时已回避表决。因此，我们同意《关于追加 2023 年度公司日常关联交易额度预计的议案》。 1 三、关于聘任公司副总裁的议案 根据《上市公司独立董事规则》、《深圳证券交易所创业板股票上市规则》等 法律法规及《公司章程》的有关规定，作为辽宁奥克化学股份有限公司（以下简称 "公司"）的独立董事，本着认真、负责的态度，对公司第六届董事会第七次会议 审议的相关议案发表如下独立意见： 一、关于公司关联方资金占用及对外担保情况的专项意见 经核查，公司在控股股东及其他关联方资金往来、对外担保方面能够严格遵守 《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要求》等相关 法律法规及《公司章程》的有关规定。 公司不存在 ...